Product Information

OXYBUTYNIN CL ER 10 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0978 per EA under NDC 62135050890. Its NADAC has been published 167 times since Jun 14, 2023.

FDA first approved this application on Feb 4, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXYBUTYNIN CL ER 10 MG TABLET

OXYBUTYNIN CHLORIDE
$0.0978per EA

Strength

10 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135050890

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OXYBUTYNIN CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078503

FDA Approved

2/4/2009

TE Code

AB

On Market Since

3/1/2009

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for OXYBUTYNIN CL ER 10 MG TABLET has been published 167 times since Jun 14, 2023, and over the history we have for it it has declined 20.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0978 per EA
All-time high$0.1240 (Dec 13, 2023)
All-time low$0.0837 (Nov 20, 2024)
52-week high$0.1089
52-week low$0.0978
Median price$0.1070
Average price$0.1066
Largest weekly change+35.2% (Jun 19, 2024)
Weeks tracked167
Tracking sinceJun 14, 2023

Price History

1W

-1.1%

1M

-1.1%

3M

-5.1%

6M

-6.3%

1Y

-9.2%

3Y

-14.3%

5Y

N/A

All

-20.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OXYBUTYNIN CHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OXYBUTYNIN CL ER 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 10 MG TABLET, manufactured by Chartwell RX LLC, is $0.0978 per EA (NDC 62135050890), effective Aug 19, 2026.

How has the price of OXYBUTYNIN CL ER 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has declined 20.3%. It has been tracked across 167 weekly CMS publications since Jun 14, 2023.

What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 10 MG TABLET?

Since Jun 14, 2023, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.1240 (Dec 13, 2023), with a median of $0.1070 per EA.

Are there cheaper alternatives to OXYBUTYNIN CL ER 10 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of OXYBUTYNIN CL ER 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OXYBUTYNIN CL ER 10 MG TABLET?

OXYBUTYNIN CL ER 10 MG TABLET (NDC 62135050890) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.